GE Healthcare to Acquire Xcellerex, Inc., Broadening Capabilities in Growing Biopharmaceutical Manufacture Segment
Published: Mar 07, 2012
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare, a unit of GE (NYSE:GE) announced today it has reached an agreement to acquire Xcellerex, Inc. a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines. The strong strategic fit between the two companies, combined with expanded capabilities in product development and marketing, will offer significant customer benefits. Financial terms were not disclosed.